Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by CIBC Asset Management Inc

CIBC Asset Management Inc cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 167,721 shares of the medical equipment provider’s stock after selling 22,101 shares during the period. CIBC Asset Management Inc’s holdings in Intuitive Surgical were worth $87,544,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Creative Planning increased its position in Intuitive Surgical by 9.3% during the third quarter. Creative Planning now owns 68,881 shares of the medical equipment provider’s stock worth $33,839,000 after buying an additional 5,842 shares during the period. Howard Capital Management Group LLC grew its position in Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the last quarter. Claro Advisors LLC raised its holdings in shares of Intuitive Surgical by 54.8% in the third quarter. Claro Advisors LLC now owns 1,398 shares of the medical equipment provider’s stock valued at $687,000 after buying an additional 495 shares during the last quarter. Stratos Wealth Partners LTD. boosted its stake in shares of Intuitive Surgical by 5.8% during the third quarter. Stratos Wealth Partners LTD. now owns 17,663 shares of the medical equipment provider’s stock worth $8,677,000 after buying an additional 976 shares during the period. Finally, Stratos Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 2.7% during the third quarter. Stratos Wealth Advisors LLC now owns 6,095 shares of the medical equipment provider’s stock worth $2,994,000 after buying an additional 162 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $595.55 on Monday. The company has a 50-day simple moving average of $559.48 and a 200-day simple moving average of $520.19. The company has a market cap of $212.12 billion, a PE ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Wall Street Analyst Weigh In

ISRG has been the topic of several analyst reports. Piper Sandler reiterated an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Truist Financial boosted their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Stifel Nicolaus increased their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Finally, UBS Group increased their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock worth $3,587,582 over the last quarter. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.